Notice of 43rd Annual General Meeting (AGM)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has called its 43rd AGM for September 25, 2025 at 3:00 p.m., to be held via video conferencing. Shareholders will vote on adopting audited standalone and consolidated financial statements for FY ending March 31, 2025, and on re-appointing director Mr. Parikh H. A. who retires by rotation. Key resolutions include regularising Mr. Hitesh Pradeep Rijwani as Non-Executive Independent Director for 5 years (till May 2030) and Mr. Sarang Bharatbhai Pathak as Non-Executive Non-Independent Director. The meeting will also appoint Mr. Chintan K. Patel as Secretarial Auditor for 5 years (FY 2025-26 to FY 2029-30). Most notably, shareholders will vote on a major alteration to the company's object clause (MOA) to add new business areas including agro products, solar/renewable energy, power and infrastructure, real estate, drones, IT/software, data centres, and cloud services. E-voting runs from September 22 to September 24, 2025, with cut-off date of September 19, 2025.
The MOA amendment is the biggest red flag — the company is seeking shareholder approval to expand far beyond its bioscience core into unrelated sectors like real estate, drones, and cloud services, signalling a major strategic pivot or diversification push that existing investors should evaluate carefully. New director appointments and the 5-year secretarial auditor tenure are routine governance items with neutral impact.